Salivary gland tumors are a very heterogeneous group of nosological entities with various clinicopathological features and biological behaviour. Acinic cell carcinoma (ACC) comprises about 17% of all salivary gland cancers.\[[@ref1]\] ACC exhibits a serous acinar cell differentiation characterized by cytoplasmic zymogen secretory granules.\[[@ref1]\] In contrast to other malignancies, ACC occurs more frequently in young people. More than 16% of the patients are under the age of 30.\[[@ref1]\] In this younger population, female patients comprise a significantly greater proportion of the cases.\[[@ref1]\] ACC is generally restricted (92%) to the parotid gland.\[[@ref2]\] Exceptionally, it may affect both parotid glands in a single individual. Bilateral occurrence may be either synchronous (simultaneous coexistence at the time of diagnosis) or metachronous (consecutive development after a certain time) in presentation. Only a few such cases have been reported in the literature until now, which remained under-researched.\[[@ref2]--[@ref14]\] this study presents a unique case of ACC with an involvement of both parotid glands in a young woman, in whom the second primary tumor on the contralateral side occurred after a long time from a development of the first lesion.

Case Report {#sec1-2}
===========

In 2007, a 26-year old female with unremarkable medical history was diagnosed to have a tumor mass in the left parotid gland. Ultrasonography (USG) revealed a well-demarcated, hypoechogenic solid tumor 14 mm in diameter, as well as lymphadenopathy in the left side of the neck. A left superficial parotidectomy with a regional cervical lymph node extirpation was performed. Histology of the resected tumor confirmed a low-grade ACC with the neoplastic cell population predominantly arranged in solid-lobular pattern and surrounded by a dense lymphoid stroma containing the lymphoid follicles ([Fig. 1](#F1){ref-type="fig"}). Tumor cells contained PAS (Periodic Acid-Schiff) positive ([Fig. 2](#F2){ref-type="fig"}) and diastase-resistant intracytoplasmic granules. Immunohistochemically, they were strongly positive for pan-cytokeratin, CEA, CK7, focally positive for S-100 protein, and negative for alpha-SMA. The Ki-67 proliferation index was \<5%. Resection margins were free of tumor. Resected lymph node did not show metastatic infiltration. The patient was referred to the oncological dispensary care without further oncological therapeutic intervention. She underwent regular medical check-ups at the Otorhinolaryngology Department (at least once a year), including USG scans. During a follow-up period (11 years), she had not any signs of local recurrence or metastasis. However, in May 2018, at the age of 37, she recognized a painless swelling in the right preauricular region, accompanied by cervical lymphadenopathy. Magnetic resonance imaging (MRI) showed an irregular hypoechogenic tumor mass in the right parotid gland. The lesion measured 12 mm, it was multilobulated with no evidence of extraglandular propagation. Positron emission tomography and computed tomography (PET/CT) confirmed an increased accumulation of fluourodeoxyglucose in the lower pole of the gland. A USG-guided core needle biopsy was performed, and microscopy suggested a diagnosis of ACC. Shortly thereafter, a right superficial parotidectomy with a regional lymph nodes dissection was done. Histology confirmed a low-grade ACC showing the same picture as it was found in the left parotid gland ([Fig. 3](#F3){ref-type="fig"}). It immunohistochemically expressed CK7, CK8/18 and CK19, while it was negative for CK20, p63 and alpha-SMA. Neoplastic cells contained abundant PAS-positive, diastase-resistant cytoplasmic granules ([Fig. 4](#F4){ref-type="fig"}). Due to fragmentation and artificial changes of biopsy tissue, it was not possible to reliably comment on the resection margins. All lymph nodes (eight) were free of tumor. After surgery, re-excision of the parotid gland and local radiation therapy were considered, but eventually (with respect to the patient's wish and in an effort to avoid facial nerve injury) they were abandoned. The patient underwent stringent medical check-ups, including the imaging exams. A year after the operation, she was without evidence of locoregional recurrence or metastasis.

![The first ACC arising in the left parotid gland. A solid-nodular growth pattern of the neoplastic epithelium. The tumor cell population resembles normal serous acinar salivary gland cells (hematoxylin & eosin, 40x).](MBSEH-53-306-g001){#F1}

![PAS staining (the case presented in [Figure 1](#F1){ref-type="fig"}). A multilobular microarchitecture of tumor tissue. The eosinophilic material in the cytoplasm of the neoplastic cells shows a strong purple color (20x).](MBSEH-53-306-g002){#F2}

![The second ACC arising in the right parotid gland. The tumor has the same microscopic appearanceas in the previous case (hematoxylin & eosin, 100x).](MBSEH-53-306-g003){#F3}

![PAS diastase staining (the case presented in [Figure 3](#F3){ref-type="fig"}). Purple color of the neoplastic cells does persist after digestion with a diastase (100x).](MBSEH-53-306-g004){#F4}

Discussion {#sec1-3}
==========

In routine otorhinolaryngology practice, bilateral involvement of major salivary glands by carcinoma of an identical histologic subtype is uncommon. In this journal, an interesting case report of bilateral synchronous mucoepidermoid carcinoma of the parotid gland has been recently published by Akpinar et al.\[[@ref15]\] Among epithelial malignancies, ACC is thought to possess the highest propensity to affect both parotid glands (\<5% of all cases) in a single person.\[[@ref2]--[@ref4]\] However, due to the rarity, there are limited data regarding the incidence of this phenomenon. We have found fifteen case reports describing an occurrence of ACC in both parotid glands in one patient that are summarized in [Table 1](#T1){ref-type="table"},\[[@ref2]--[@ref14]\] including the present case. Mean age of the patients was 49.3 years. Six individuals (37.5 %) were young females up to 37 years old age. Most of the cases (75%) exhibited a simultaneous occurrence of carcinomas in both parotid glands at the time of diagnosis. We have discovered only three patients, in whom the second primary cancer developed in the contralateral parotid gland after a certain period of time from the recognition and treatment of the first tumor. Our patient represents the fourth such case published in the literature. Moreover, among those documented cases, the findings demonstrates the longest interval (11 years) between the diagnosis of both primary lesions. Therefore, there is no doubt that a prolonged follow-up is mandatory after treatment in all cases.

###### 

A summary of the clinicopathologic findings of the patients manifesting with a bilateral development of ACC in the parotid gland

  Ref.        Age     Sex      Development of the tumors
  ----------- ------- -------- ---------------------------------------------
  \(2\)       20      Female   Synchronous occurrence
  \(3\)       50      Female   Synchronous occurrence
  \(4\)       22      Female   Synchronous occurrence
  \(5\)       64      Male     Synchronous occurrence
  \(6\)       52      Male     Synchronous occurrence
  \(7\)       55      Female   Synchronous occurrence
  \(8\)       35/36   Female   Metachronous occurrence (interval 1 year)
  \(9\)       71      Male     Synchronous occurrence
  \(9\)       55      Female   Synchronous occurrence
  \(10\)      32      Female   Synchronous occurrence
  \(11\)      57      Female   Synchronous occurrence
  \(12\)      77      Female   Synchronous occurrence
  \(13\)      55/58   Female   Metachronous occurrence (interval 3 years)
  \(14\)      36      Female   Synchronous occurrence
  \(14\)      60/68   Male     Metachronous occurrence (interval 8 years)
  This case   26/37   Female   Metachronous occurrence (interval 11 years)

Conclusion {#sec1-4}
==========

Although metachronous bilateral ACC of the parotid gland is very rare, it is occasionally encountered in medical practice. This case report demonstrates that such an event may occur many years after a diagnosis of the initial tumor. Every patient once treated for parotid ACC warrants periodical clinical examinations and long-term follow-up (more than 10 years), even with attention to the contralateral non-affected parotid gland.
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